Company Filing History:
2 out of 3,693 
1 out of 1 
1 out of 28 
Years Active: 2003-2018
Title: J Thomas Buckley: Innovator in Prostate Treatment
Introduction
J Thomas Buckley is a notable inventor based in Victoria, Canada. He has made significant contributions to the field of medical treatments, particularly in addressing benign prostatic hyperplasia (BPH) and prostate cancer. With a total of 4 patents to his name, Buckley's work showcases innovative approaches to complex health issues.
Latest Patents
One of Buckley's latest patents is a method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins. This invention provides a method that utilizes modified pore-forming proteins (MPPs) derived from naturally occurring cytotoxic proteins. These MPPs are designed to selectively target and kill normal prostate cells, offering a potential breakthrough in BPH treatment. Another significant patent involves modified proaerolysin peptides, which include prostate-specific protease cleavage sites and binding domains. This invention outlines methods for using these peptides to treat prostate cancer, further emphasizing Buckley's commitment to advancing medical science.
Career Highlights
Throughout his career, Buckley has worked with prestigious institutions, including The Johns Hopkins University. His research and innovations have contributed to the understanding and treatment of prostate-related health issues, making him a respected figure in the medical community.
Collaborations
Buckley has collaborated with notable professionals in his field, including Samuel Ray Denmeade and John Tod Isaacs. These partnerships have likely enhanced the impact and reach of his inventions.
Conclusion
J Thomas Buckley's innovative work in the treatment of prostate conditions highlights his dedication to improving patient outcomes. His patents reflect a deep understanding of medical challenges and a commitment to finding effective solutions.